Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January. By Jan. 23 — less than three weeks after it became available — ...

The medication is really taking care of business. A pair of new Canadian clinical trials show poop pills can reduce the toxic side effects of cancer medications and even support patient response to ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

Relations among brand-name GLP-1 manufacturers and compounding pharmacies are deteriorating as weight loss pills enter the U.S. market and competition intensifies. Hims & Hers is selling the ...

Novo Nordisk said it will take legal action again telehealth provider Hims & Hers after Hims announced a cheaper copycat version of Novo's Wegovy weight loss pill. Hims said it would sell a copy of ...

Novo Nordisk has launched its Wegovy GLP-1 drug in pill form. Amazon is getting into the fight, offering ease and low costs to customers who buy the Wegovy pill on its platform. Up until 2026, GLP-1 ...

If you have obesity and are curious whether a weight loss medication could help you improve your health, there are a number of weight loss pills on the market to consider, both old and new.

There’s a new semaglutide pill entering the weight-loss market, and it’s aiming to undercut the competition. Hims & Hers, the online pharmaceutical retailer, announced plans to launch a compounded, ...

Jan 30 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab Wegovy pill hit over 26,000 U.S. prescriptions in the second full week after its launch, IQVIA data shared by an analyst on Friday showed.

FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...

Yes, Wegovy is available in a pill form. Originally, it was only available as a weekly injection, but the Food and Drug Administration (FDA) approved a daily tablet version in December 2025. The ...

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition with Novo Nordisk in the U.S. obesity-drug market. Shares of of Hims & Hers ...